Characterization of the Gating Conformational Changes in the Felbamate Binding Site in NMDA Channels  by Chang, Huai-Ren & Kuo, Chung-Chin
Characterization of the Gating Conformational Changes in the Felbamate
Binding Site in NMDA Channels
Huai-Ren Chang* and Chung-Chin Kuo*y
*Department of Physiology, National Taiwan University College of Medicine, Taipei, Taiwan; and yDepartment of Neurology, National
Taiwan University Hospital, Taipei, Taiwan
ABSTRACT The anticonvulsant effect of felbamate (FBM) is ascribable to inhibition of N-methyl-D-aspartate (NMDA) currents.
Using electrophysiological studies in rat hippocampal neurons to examine the kinetics of FBM binding to and unbinding from the
NMDA channel, we show that FBM modiﬁes NMDA channel gating via a one-to-one binding stoichiometry and has quan-
titatively the same enhancement effect on NMDA and glycine binding to the NMDA channel. Moreover, the binding rates of FBM
to the closed and the open/desensitized NMDA channels are 187.5 and 4.6 3 104 M1 s1, respectively. The unbinding rates
of FBM from the closed and the open/desensitized NMDA channels are ;6.2 3 102 and ;3.1 s1, respectively. From the
binding and unbinding rate constants, apparent dissociation constants of ;300 and ;70 mM could be calculated for FBM bind-
ing to the closed and the open/desensitized NMDA channels, respectively. The slight (approximately fourfold) difference in FBM
binding afﬁnity to the closed and to the open/desensitized NMDA channels thus is composed of much larger differences in the
binding and unbinding kinetics (;250- and ;60-fold difference, respectively). These ﬁndings suggest that the effects of NMDA
and glycine binding coalesce or are interrelated before or at the actual activation gate, and FBM binding seems to modulate
NMDA channel gating at or after this coalescing point. Moreover, the entrance zone of the FBM binding site very likely under-
goes a much larger conformational change along the gating process than that in the binding region(s) of the binding site. In
other words, the FBM binding site becomes much more accessible to FBM with NMDA channel activation, although the spatial
conﬁgurations of the binding ligand(s) for FBM themselves are not altered so much along the gating process.
INTRODUCTION
It has been found that N-methyl-D-aspartate (NMDA) chan-
nel antagonists possess a broad-spectrum antiepileptic effect
on experimental seizures (1). In clinical trials, however, most
NMDA channel antagonists have demonstrated serious neu-
robehavioral complications that have limited further phar-
maceutical development (2). Felbamate (FBM; 2-phenyl-1,
3-propanediol dicarbamate) is the onlymarketed anticonvulsant
that shows evident NMDA channel inhibitory effect at ther-
apeutic concentrations (3–6). Although some side effects (e.g.,
idiosyncratic hematologic and hepatic toxicities) have pre-
cluded its use as the ﬁrst-line antiepileptic therapy, FBM has
remained as an important therapeutic option for different types
of seizures that are refractory to the other anticonvulsants in
both children and adults (7–9).
FBM has been shown to inhibit [3H]5,7-dichlorokynure-
nic acid (DCKA, a high-afﬁnity competitive glycine site an-
tagonist) binding in the rat brain (10,11). Glycine was also
reported to compensate the antiepileptic action of FBM in the
NMDA-induced seizures (12), and the inhibitory effect of
FBM on Ca21 inﬂuxes induced by NMDA/glycine exposure
in cultured cerebellar granular cells (13). These studies sug-
gested that FBM competed with glycine binding to the NMDA
channel. However, Subramanian et al. (6) showed that FBM
competitively inhibited [3H]MK-801 binding but not [3H]5,7-
DCKA binding. Also, exogenous addition of glycine failed
to modulate the excitoprotective effect of FBM on cultured
cortical neurons exposed to glutamate or NMDA (14), and
there were no competitive interactions between FBM and
glycine in studies of NMDA currents (5). Furthermore, it has
been reported that FBM produced an increase rather than a
decrease in [3H]glycine binding to the NMDA channel (15).
These reports are seemingly complicated or even conﬂicting.
FBM thus probably has an effect on glycine binding, but the
details remain to be deﬁned.
We have demonstrated that FBM has a higher afﬁnity to
the open and especially the desensitized NMDA channels
(dissociation constant;55–110mM) than to the closed chan-
nels (dissociation constant;200 mM) (4). Also, FBM slows
the recovery from desensitization in the NMDA channel. The
selective binding of FBM to the open/desensitized channels
well explains the use-dependent inhibition of NMDA cur-
rents and consequently the nonsedative anticonvulsant effect
of FBM. FBM thus is an effective gating modiﬁer of the
NMDA channel at its therapeutic concentrations (50–300mM).
The overall gating conformational changes in the FBM bind-
ing site, however, do not seem to be dramatic, considering
the small (approximately two-to-fourfold) difference in FBM
afﬁnity to the closed and to the open/desensitized NMDA
channels (4). To characterize the molecular action of FBM in
more detail, we explored the kinetics of FBM binding to and
unbinding from the NMDA channel, as well as the effect of
FBM on the afﬁnity of NMDA or glycine to the channel. We
ﬁnd that FBM has quantitatively the same effect on both the
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NMDA and glycine binding to the NMDA channel, indicat-
ing that the effects of NMDA and glycine binding coalesce
or are interrelated before or at the actual activation gate, and
FBM binding seems to modulate NMDA channel gating at or
after this coalescing point with a one-to-one binding stoichio-
metry (one FBM per NMDA channel). Most interestingly,
FBM has much faster binding and unbinding rates (;250-
fold and;60-fold, respectively) to the open/desensitized than
to the closed NMDA channels. The latter ﬁndings strongly
suggest that the FBM binding site in the NMDA channel be-
comes much more accessible to FBM after channel activa-
tion, signaling a much larger gating conformational change




Neonatal (7- to 14-day-old) Wistar rats were used for the preparation of
coronal slices of the whole brain. The CA1 region of hippocampus dissected
from the slices was cut into small chunks. Tissue chunks were treated with
protease XXIII (1 mg/ml; Sigma, St. Louis, MO) in dissociation medium
(82 mM Na2SO4, 30 mM K2SO4, 3 mMMgCl2, and 5 mM HEPES, pH 7.4)
for 3–5 min at 35C, and then were moved into dissociation medium
containing no protease but bovine serum albumin (1 mg/ml; Sigma). Each
time two to three chunks were picked and triturated to release single neurons
for whole-cell recordings.
Electrophysiological recordings
Acute dissociated neurons were placed in a recording chamber ﬁlled with
Tyrode’s solution (150 mM NaCl, 4 mM KCl, 2 mM MgCl2, 2 mM CaCl2,
and 10 mM HEPES, pH 7.4). The ﬁre-polished pipettes pulled from bo-
rosilicate capillaries (1.55–1.60 mm outer diameter; Hilgenberg, Malsfeld,
Germany) were used for whole-cell recordings. When ﬁlled with the internal
solution (75 mM CsCl, 75 mM CsF, 10 mM HEPES, and 5 mM EGTA,
pH 7.4), the pipettes had resistances of 1–2 MV. After the whole-cell
conﬁguration was obtained in Tyrode’s solution, the cell was lifted and
moved in front of a set of square-glass three-barrel tubes (0.6 mm internal
diameter) or theta-glass tubes (2.0 mm outer diameter pulled to an opening
of;300 mm in width; Warner Instruments, Hamden, CT) emitting different
external recording solutions. The standard external solution was Mg21-free
Tyrode’s solution (pH 7.4) containing 0.5 mM tetrodotoxin. The holder of
glass tubes was connected to a stepper control (SF-77B perfusion system,
Warner Instruments) to carry out fast switches between different glass tubes
and thus rapid solution exchange. The rate of solution exchange was quan-
tiﬁed by the method described previously (4). In short, the rate of change in
current amplitude between two different external solutions containing different
cations, namely Tyrode’s solution and a solution of the same constituents,
except that the Na1 ion was replaced with the impermeable N-methyl-D-
glucamine ion. The 50% current change time is ;6 ms and ;40 ms for the
theta-glass and the square-glass, respectively (4). Theta-glass tubes were
thus used in the experiments studying the kinetics of FBM binding to and
unbinding from the channel in Figs. 5 and 8, which require a better res-
olution in the time domain. In the other experiments, square-glass tubes were
used to facilitate the switch between a larger number of different external
solutions. NMDA and glycine (Sigma) were dissolved in water and FBM
(Tocris Cookson, Bristol, UK) was dissolved in dimethyl sulfoxide to make
100, 10, and 100 mM stock solutions, respectively. The stock solutions were
diluted into Mg21-free Tyrode’s solution to make 0.1 mM to 1 mM NMDA,
10 nM to 30 mM glycine, and 10 mM to 1 mM FBM right before the
experiment. Three-hundred micromolar was the most commonly used con-
centration of FBM for the characterization of the gating-modiﬁcation effects
because it is within the therapeutic concentration range (50–300 mM) (16,17),
and because submillimolar FBM chieﬂy behaves as a gating modiﬁer (4).
The ﬁnal concentration of dimethyl sulfoxide (&;1%) was found to have
no detectable effect on NMDA currents. The NMDA currents were recorded
at a membrane potential of 70 mV and at room temperature (;25C) with
an Axoclamp 200A ampliﬁer, ﬁltered at 1 kHz with a four-pole Bessel ﬁlter,
digitized at 200–500 ms intervals, and stored using a Digidata-1322A analog/
digital interface as well as the pCLAMP software (all from Axon Instru-
ments, Union City, CA). All data are expressed as mean6 SE. For comparisons
between experimental groups, the Student’s t-test was used and p , 0.05
was considered as statistically signiﬁcant.
RESULTS
FBM binding increases the afﬁnity of NMDA
to the NMDA channel
We have shown that FBM has a higher afﬁnity to the open/
desensitized state than to the closed state of NMDA channels
(4). Because NMDA channel activation and desensitization
are conformational changes triggered by NMDA binding, it
is very likely that FBM binding also increases the afﬁnity of
NMDA to the NMDA channel. To quantify NMDA afﬁnity
to the NMDA channel, we chose the steady-state data (late-
sustained currents) to estimate the dissociation constant of
NMDA binding to the resting channel. The NMDA concen-
tration-response curves are constructed by application of dif-
ferent concentrations of NMDA with 0.3 mM glycine in the
absence and presence of 300 mM FBM (Fig. 1 A). Fig. 1 B
shows two simple gating schemes of the NMDA channel.
Two molecules of NMDA are presumed to bind to two bind-
ing sites on the NMDA receptor before the channel could
open. As a ﬁrst approximation, these two sites are assumed to
have the equal binding afﬁnity to NMDA, and the binding of
one NMDA molecule will not affect the binding of the other.
The relative steady-state occupancy of states C, CN, CN2,
ON2, and DN2 thus are 1, 2[N]/Kn, ([N]/Kn)
2, p3 ([N]/Kn)
2,
and m 3 p 3 ([N]/Kn)
2, respectively, in which [N] is the
concentration of NMDA, Kn is the dissociation constant of
NMDA binding to either of the two sites in the closed state,
p is the relative probability that the channel would be open
(versus remaining closed) when both sites are bound with
NMDA molecules, and m is the ratio between the steady-
state distribution of the desensitized and the open states.
The amplitude of the steady-state NMDA current (I) is pro-
portional to the ratio between the number of open and total
channels, or
I ¼ kðON2=ðC1CN1CN21ON21DN2ÞÞ
¼ kðp=ð11 ð2Kn=½NÞ1 ðKn=½NÞ21 p3 ð11mÞÞÞ;
where k is a constant for conversion and is in the unit of
current (mA).
If [N] is very large or [N]  Kn, then I approaches its
maximum (Imax) and the equation above is simpliﬁed to
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Imax ﬃ kðp=ð11 p3 ð11mÞÞÞ:
The relative steady-state current therefore could be expressed
as
I=Imax ¼ð11 p3 ð11mÞÞ=ð11 ð2Kn=½NÞ
1 ðKn=½NÞ21 p3 ð11mÞÞ: (1)
The best ﬁt with Eq. 1 to the data points in the control con-
dition gives Kn ¼ 54 mM (with p and m values ﬁxed at 2.6
and 4, respectively; see also (4)). With the same ﬁxed pa-
rameters, the data in 300 mM FBM can be best ﬁtted with
Kn ¼ 27 mM, indicating a twofold increase in the afﬁnity of
NMDA to the NMDA channel in the presence of 300 mM
FBM. Alternatively, one may ﬁx Kn at 54 mM, and ﬁt for
p. The best ﬁt to the data in 300 mMFBM then gives p¼ 8.1,
indicating that NMDA channels bound with two NMDA
molecules have roughly a threefold higher chance of opening
in 300 mM FBM. These results provide a quantitative de-
scription of the modiﬁcation effect of FBM on the gating
process of the NMDA channel, and are very much consistent
with the small but signiﬁcant (two-to-fourfold) differences in
the binding afﬁnity of FBM toward different gating states of
the NMDA channel (4).
FBM cannot elicit NMDA currents by itself but
enhances the currents elicited by very low
concentrations of NMDA
If FBM binding effectively alters the conformation of the
NMDA channel, moving the resting (closed) channel toward
the open state and thus increasing the afﬁnity of NMDA, it
would be interesting to see whether FBM itself can elicit
NMDA currents in the complete absence of NMDA. After
repeated trials we cannot demonstrate discernible currents
with FBM and glycine in the absence of NMDA (Fig. 2 A),
although FBM indeed enhances rather than inhibits the cur-
rent elicited by a very low concentration (4 mM) of NMDA
(Fig. 2 B). These ﬁndings imply that FBM is a partial but not
a full allosteric agonist of the NMDA binding site, because
FBM binding would increase the efﬁcacy of NMDA binding
to the NMDA (or glutamate) site, but FBM binding by itself
cannot replace NMDA and move the NMDA channel to the
open conformation.
FBM binding also allosterically interacts with the
glycine site
We have argued that FBM is a partial allosteric agonist of the
NMDA channel and increases the afﬁnity of NMDA to the
NMDA channel. Glycine is essential for NMDA channel ac-
tivation and is described as a coagonist of glutamate (18,19).
Since an allosteric interaction between the NMDA and gly-
cine binding sites of the NMDA channel has been well estab-
lished (20,21), we also investigated the interaction between
FBM and glycine binding on the NMDA channel (Fig. 3).
NMDA currents were elicited by application of saturating con-
centrations of NMDA (1 mM) and different concentrations of
glycine in the absence and presence of 300 mM FBM. It is
interesting that FBM signiﬁcantly inhibits the current in the
presence of 30 mM glycine, but has only negligible inhib-
itory effect on the current with 0.1 mM glycine (Fig. 3 A).
Fig. 3, B and C, shows that FBM decreases the maximum
FIGURE 1 FBM modiﬁcation of the NMDA concentration-response
curves. (A) NMDA currents were elicited by application of 0.3 mM glycine
and different concentrations of NMDA in the absence (control) and presence
of 300 mM FBM. The relative current is deﬁned as the ratio between the
sustained current amplitude in different concentrations of NMDA and that in
1 mM NMDA (approximating the Imax in Eq. 1), and is plotted against the
NMDA concentration (n¼ 6–9). The same experiments were repeated in the
absence (control) and presence of 300 mM FBM with each set of data
separately normalized to their respective Imax, which is smaller in FBM than
in control (data not shown; see also (4)). Note that FBM shifts the NMDA
concentration-response curve to the left, indicating an enhancement effect on
the NMDA afﬁnity. Quantitatively, the solid lines are best ﬁts to the data
points using Eq. 1 with p- and m-values ﬁxed at 2.6 and 4, respectively (see
also (4)). The Kn values given by the best ﬁts are 54 and 27mM in the control
condition and 300 mM FBM, respectively. One may also ﬁx Kn at 54 mM
and ﬁt for the p-value in 300 mM FBM. In this case, the best ﬁt gives p¼ 8.1
and a ﬁtting curve (dotted line) very similar to that with p¼ 2.6 and Kn¼ 27
mM. (B) Two simple gating schemes describe that two molecules of NMDA
bind to the channel and thus result in opening and desensitization. The
closed, open, and desensitized states of the channel are denoted by C, O, and
D, respectively. The NMDA molecule is represented by N. The closed
channels with one and two bound molecules of NMDA are indicated by CN
and CN2, respectively. Although the NMDA channel may not necessarily
open before being desensitized ((34); but see (35)), we chose the basic C-O-
D linear scheme (in the upper panel) for the sake of simplicity, and also for
the possible coupling between channel opening and desensitization. Because
the data analysis here is based on steady-state considerations, the major
conclusions should remain similar if one chooses more complicated schemes
like the one in the lower panel.
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response elicited by 1 mM NMDA with a decrease in the
EC50 of glycine, indicating an enhancement effect on glycine
binding by FBM. To have a more quantitative analysis of the
glycine afﬁnity to the NMDA channel, we took an approach
similar to that in Fig. 1. With saturating concentrations of
NMDA, the relative steady-state current in different concen-
trations of glycine could be given by
I=Imax ¼ð11 p3 ð11mÞÞ=ð11 ð2Kgly=½glyÞ
1 ðKgly=½glyÞ21 p3 ð11mÞÞ; (2)
where [gly] is the glycine concentration, Kgly is the dissocia-
tion constant of glycine binding to either of the two glycine
binding sites in the closed channel, p is the relative chance
that the channel is open (versus staying closed) when both
sites are occupied by glycine, and m is the ratio between the
steady-state occupancy of the desensitized state and the open
state.
It has been suggested that glycine could decrease desen-
sitization of the NMDA channel (22,23). Here the m-value
also becomes smaller with increasing concentrations of gly-
cine in our study. For example, the peak current in Fig. 3 A is
approximately six times and approximately four times the
size of the sustained current in 0.1 and 30 mM glycine, respec-
tively. We therefore set the p-value at 1 and the m-value at
5 (0.1 mM glycine) or 3 (30 mM glycine) as a ﬁrst approx-
imation in the analysis of the data points in the control con-
dition in Fig. 3 C. One may obtain very similar ﬁts with Kgly
values of 308 and 243 nM with m-values set at 5 and 3,
respectively. It is interesting that the Kgly values remain
relatively constant (308 and 243 nM) with different m-values,
and are consistent with the previously reported EC50 (e.g.,
185 nM in (23); 290 nM in (22); and 430 nM in (3)) of
glycine to the NMDA channel despite the different exper-
imental approaches in different studies. On the other hand,
with the same ﬁxed parameters, the data in 300 mMFBM can
be best ﬁtted with Kgly ¼ 165 (m set at 5) and 129 nM (m set
at 3), indicating a twofold increase in the afﬁnity of glycine
to the NMDA channel in the presence of 300 mM FBM.
Alternatively, one may also ﬁx Kgly at 308 (m set at 5) or 243
nM (m set at 3), and ﬁt for p. The best ﬁt to the data in 300
mM FBM then gives p ¼ 2.6, suggesting that glycine-bound
channels have a 2.6-fold higher chance of opening in 300
mM FBM than in the control condition. It is intriguing that
300 mM FBM has quantitatively the same effects on the
NMDA and glycine binding to the NMDA channel (i.e., ap-
proximately twofold increase in the NMDA or glycine bind-
ing afﬁnity, or alternatively, an approximately threefold increase
in the opening probability of the NMDA- and glycine-bound
channel). This quantitative similarity suggests that the effects
of NMDA and glycine binding coalesce or are interrelated at
or before the actual activation gate, and FBM binding seems
to modulate channel gating at or after this coalescing point.
In other words, the FBM binding site is probably close to or
right at the actual activation gate, which should be controlled
by an integrative effect, rather than a simple summation of each
individual effect, of NMDA and glycine binding to the different
subunits of the channel. FBM may thus affect the NMDA or
glycine binding in each different subunit to a similar extent
via a similar allosteric mechanism (see below and Discussion).
FBM potentiates the currents elicited by very low
concentrations of glycine
We have seen that FBM enhances rather than inhibits the
NMDA currents elicited by very low concentrations of NMDA
in Fig. 2. We therefore also investigated the effect of FBM
on the NMDA currents elicited in the presence of a very low
concentration (0.01 mM) or in the complete absence of gly-
cine (Fig. 4). One-millimolar NMDA could elicit very small
currents in the absence of glycine. We found that FBM does
not deﬁnitely enhance this very small current elicited by 1 mM
NMDA (Fig. 4 A). However, the small currents elicited by
application of 0.01 mM glycine with 1 mM NMDA are ev-
idently potentiated by 10–300 mM FBM (Fig. 4, B and C).
These ﬁndings are very similar to those in Fig. 2, and are
again consistent with the idea of similar interactions between
FBM andNMDA and between FBM and glycine in the NMDA
channel.
FBM binds to the activated NMDA channel with a
simple bimolecular reaction
We have argued that FBM binding allosterically interacts with
both NMDA and glycine binding in the NMDA channel, and
FIGURE 2 FBM enhancement of the NMDA currents elicited by very
low concentrations of NMDA. (A) No discernible currents were elicited by
application of 300 mM FBM and 0.3 mM glycine in the absence of NMDA.
(B) 300 mM FBM enhances rather than inhibits the current elicited by a very
low concentration (4 mM) of NMDA.
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thus FBM effectively modiﬁes the gating process of the
NMDA channel. The overall gating conformational changes
in the FBM binding site, however, do not seem to be dra-
matic. The afﬁnity change of NMDA or glycine binding to
the NMDA channel is only approximately twofold by FBM
(Figs. 1 A and 3 C), and there is only an approximately two-
to-fourfold difference between FBM afﬁnity to the closed
and to the open/desensitized NMDA channels (4). To char-
acterize the molecular basis of the seemingly small gating
conformational changes in the FBM binding site based on
the steady-state data, we explored the kinetics of FBM bind-
ing to and unbinding from the NMDA channel. Fig. 5, A and
B, demonstrates the kinetics of inhibition and relaxation of
1 mM NMDA-evoked steady-state currents by 100, 300, or
1000 mMFBM. It is evident that the kinetics of inhibition are
FBM concentration-dependent, whereas the kinetics of relax-
ation are not. Fig. 5 C shows a linear correlation between the
binding rates (inverses of the binding time constants) and
FBM concentrations, indicating that FBM interacts with the
NMDA channel by a one-to-one binding process (simple bi-
molecular reaction) and a macroscopic binding rate constant
of 4.63 104 M1 s1. Moreover, the y-intercept of the linear
regression ﬁt to the macroscopic binding rate data in Fig. 5 C
is ;3.5 s1, which is well consistent with the inverses of
current relaxation (unbinding rate) time constants (;3.1
s1), a value independent of FBM concentrations from Fig. 5
B. From the binding and unbinding rate constants, an appar-
ent dissociation constant of ;70 mM could be calculated for
FBM binding to the activated NMDA channel (including
both open and desensitized states of the channel, as it is dif-
ﬁcult to completely separate the two states with our experiment
approaches here). However, if the ratio between the steady-
state occupancy of the desensitized state and the open state
is ;4 (i.e., m ¼ 4 in Fig. 1), one may roughly estimate the
dissociation constant of FBM binding to either the open
(Kf,o) or desensitized (Kf,d) NMDA channel with simple rules
of weighted average of the afﬁnity (inverse of the dissoci-
ation constant). We may then have Kf,o and Kf,d values of
;120 and;60 mM, respectively. In any case, a dissociation
constant value of ;70 mM to the mixed open and desen-
sitized states of NMDA channels or a Kf,o of;120 mM and a
Kf,d of ;60 mM are very much consistent with the pre-
viously reported dissociation constant of FBM to the open
and desensitized NMDA channels with completely different
approaches (;110 and ;55 mM, respectively) (4).
The rate of FBM binding to the resting NMDA
channel is much slower than that to the
activated channel
In Fig. 2 B, we have seen that 300 mM FBM signiﬁcantly
enhances the current evoked by a very low concentration
(4 mM) of NMDA. Here we chose 4 mM NMDA-evoked
currents and monitored the enhancement effect of FBM to
study the rates of FBM binding to and unbinding from the
resting state of the NMDA channel. An NMDA pulse length
(NMDA exposure time) of 0.3 s was carefully chosen for two
reasons: 1), 0.3 s is long enough to record clearly discernible
currents; and 2), most NMDA channels should still stay in
the resting state and thus the contaminating interaction be-
tween FBM and activated NMDA channels is minimized.
It is evident that the NMDA current gets larger and then
saturates as the preincubation with FBM gets longer (Fig. 6
A). The normalized data points in Fig. 6 B can be reasonably
FIGURE 3 FBM enhancement of glycine afﬁnity to
the NMDA channel. (A) NMDA currents were elicited
by application of saturating concentrations of NMDA
(1 mM) and different concentrations of glycine in the
absence (control) and presence of 300 mM FBM. FBM
clearly inhibits the current in the presence of 30 mM
glycine but has only negligible inhibitory effect on the
current with 0.1 mM glycine. (B) The relative current is
deﬁned as the ratio between the sustained current am-
plitude in different concentrations of glycine (and 0
or 300 mM FBM) and that in 30 mM glycine (and 0
FBM), and is plotted against the glycine concentration
(n ¼ 5–8). (C) The same data as in panel B, but the
currents in 300 mM FBM are now normalized to the
current in 30 mM glycine (and 300 mM FBM). The two
very similar solid lines are the best ﬁts to the mean data
in the control condition using Eq. 2 with a p-value of
1 and an m-value of 5 or 3, respectively. The best ﬁts
give relatively constant Kgly values of 308 and 243 nM,
respectively. With the same ﬁxed parameters, the best
ﬁts (dotted lines) to the data in 300 mM FBM give
Kgly¼ 165 (m¼ 5), and 129 nM (m¼ 3), respectively.
We also ﬁxed Kgly at 308 or 243 nM, and ﬁt for the
p-value in 300 mM FBM (dashed lines, p ¼ 2.6). Note
the close proximity between the dotted and dashed
lines.
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ﬁtted with single-exponential functions, and give binding
rate time constants of 14.5, 8.6, and 4.2 s for 100, 300, and
1000 mMFBM, respectively. In addition, the NMDA current
is enhanced to 1.5-, 2.3-, and 2.1-fold the size of the control
current by 100, 300, and 1000 mM FBM, respectively. The
enhancement effect in 1000 mMFBM is slightly smaller than
that in 300 mM FBM probably because 1000 mM FBM may
start to have mild additional pore blocking effect on the
NMDA channel (4). Fig. 6 C shows that the macroscopic
binding rates increase linearly with the FBM concentration,
again indicating a simple bimolecular reaction between FBM
and the NMDA channel. However, the linear regression ﬁt to
the data gives a binding rate constant of only 187.5 M1 s1,
a value much smaller than the binding rate constant to the
activated NMDA channel (4.6 3 104 M1 s1, Fig. 5 C).
The rate of FBM unbinding from the resting NMDA
channel is also much slower than that from the
activated channel
It is surprising that the binding rate of FBM to the resting
NMDA channel is;250-fold slower than that to the activated
NMDAchannel. This is in sharp contrast to the approximately
two-to-fourfold difference in the overall binding afﬁnity of
FBM to the resting and to the activated NMDA channels.
These data altogether strongly imply that there should also be
a large difference in the unbinding kinetics of FBM from the
resting and the activatedNMDAchannels. The possibility of a
very slow unbinding rate from the resting channel is actually
also suggested by the y-intercept of Fig. 6C (5.43 102 s1).
We therefore examine the rate of FBM unbinding from the
resting NMDA channel in more detail with a two-pulse pro-
tocol (Fig. 7). After a ﬁxed 40-s preincubation with 300 mM
FBM, the ﬁrst NMDA pulse (4 mM, 0.3 s) was given to elicit
NMDA currents as a reference. The second NMDA pulse
identical to the ﬁrst one was given after different intervals of
wash-off with FBM- and NMDA-free Tyrode’s solution for
the removal of FBM from the resting NMDA channel. As the
wash-off interval lengthened, the NMDA current in the sec-
ond pulse gradually decreased. The peak NMDA current in
the second NMDA pulse relative to the reference current is
plotted against duration of the wash-off interval to constitute
the time course of FBM unbinding form the resting channel.
The course can be reasonably ﬁtted with a single-exponential
function, giving a time constant of 16.2 s. The unbinding rate
constant of FBM from the resting channel is thus 1/16.2 or
6.2 3 102 s1. This value is very close to the y-intercept
of Fig. 6 C (5.4 3 102 s1), and is indeed ;60-fold slower
than the unbinding rate constant of FBM from the activated
NMDA channel (3.1–3.5 s1, Fig. 5). An apparent dissoci-
ation constant of ;300 mM could be calculated for FBM
binding to the resting NMDA channel (i.e., Kf,c¼;300mM)
from the binding and unbinding rate constants. ThisKf,c value
is also consistent withwhatwas previously reported based on a
completely different approach (;200 mM) (4).
The unbinding rate of FBM from the resting
NMDA channel is conﬁrmed with a different
experimental approach
Because FBM binds more strongly to the open than to the
closed NMDA channels, channel deactivation could also be
slowed by FBM.We examined the deactivation of the NMDA
channel in control and in 300 mM FBM with rapid solution
change by the use of theta-glass (Fig. 8). The decay phase
of the current upon switching the NMDA-containing exter-
nal solution back to the NMDA-free solution is ﬁtted with
single-exponential functions, giving deactivation rates (the
FIGURE 4 FBM enhancement of the NMDA currents elicited by very
low concentrations of glycine. (A and B) NMDA currents were elicited
by the same experimental protocol as that in Fig. 3, but the glycine con-
centration is decreased to 0 or 0.01 mM. FBM does not enhance the very
small current in the absence of glycine (1 mM NMDA without glycine, A).
However, the peak NMDA current elicited by 0.01 mM glycine is enhanced
by FBM in a dose-dependent fashion (B). (C) Cumulative results are
obtained from ﬁve cells with the experimental protocol described in panel B.
The relative current is deﬁned by the ratio between the amplitude of the peak
currents in 10–300 mM FBM and that in the absence of FBM (control) in the
same cell. The relative currents are 1.07 6 0.02, 1.14 6 0.02, and 1.30 6
0.04 in the presence of 10, 100, and 300 mM FBM, respectively. *p, 0.05,
compared with the control data in 0 FBM.
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inverses of the current decay time constants) of 26.3 6 1.3
and 20.7 6 1.2 s1 (p , 0.05, n ¼ 4) in the absence and
presence of FBM, respectively (Fig. 8 B). Although the slow-
ing of NMDA channel deactivation in the presence of 300
mM FBM is not dramatic, it is deﬁnite and consistent with
the slightly stronger binding of FBM to the open than to the
closed NMDA channels (e.g., Kf,o/Kf,c¼ 120 mM/300 mM). It
seems that the dissociation of NMDA (NMDA channel deac-
tivation) is signiﬁcantly faster than the dissociation of FBM
from the activated NMDA channel (rates¼;20 vs.;3 s1,
Figs. 5 C and 8 B). Based on this attribute, we tried to verify
the very slow unbinding rate of FBM from the resting NMDA
channel with one more different experimental approach (Fig.
8, C and D). FBM was applied to the steady-state activated
NMDA channel. NMDA was then washed off for 4 s, when
most FBM-bound activated channels would be converted to
either FBM-free channels or FBM-bound resting channels.
The course of current change subsequent to 4 s therefore would
mostly reﬂect the dissociation of FBM from the FBM-bound
resting channel. In other words, as the wash time is length-
ened from 4 to 32 s, more and more FBMwould unbind from
the (resting) channel. The second NMDA current thus grad-
ually increased and ﬁnally reached a similar amplitude to the
control current in the ﬁrst pulse (Fig. 8 C). The course of cur-
rent increase after 4 s can be reasonably ﬁtted with a single-
exponential function, which gives a time constant of 17.4 s
(Fig. 8 D), or an unbinding rate of 5.8 3 102 s1 for FBM
from the resting (closed) NMDA channel. This value is again
consistent with the unbinding rates of FBM from the resting
NMDA channel in Figs. 6 and 7 (5.4–6.2 3 102 s1).
DISCUSSION
FBM modiﬁes NMDA channel gating via a
one-to-one binding stoichiometry
We have seen that the rates of FBM binding to either the
resting (closed) or activated (open/desensitized) NMDA chan-
nels are linearly correlated with FBM concentrations (Figs. 5
C and 6 C), strongly suggesting that FBM binds to the
NMDA channel via a one-to-one binding process (i.e., a sim-
ple bimolecular reaction). It has been shown that the formation
FIGURE 5 Kinetics of FBMbinding to and
unbinding from the activated NMDA chan-
nel. (A) Inhibition (left panel) and relaxation
(recovery from inhibition, right panel) of the
steady-state inward NMDA (1 mM) currents
by fast application of FBM with theta-glass
tubes. (Left) The decay phase of the current
after application of FBM is well ﬁtted with
single-exponential functions to give binding
time constants of 105 and 23 ms for 100 and
1000 mMFBM, respectively. The dashed line
indicates zero current level. (Right) The incre-
ment phase of the current after wash-off of
FBM can be well ﬁtted with single-exponen-
tial functions and gives unbinding time con-
stants of 340 and 325ms for 100 and 1000mM
FBM, respectively. To avoid the effect from
incomplete solution change, the start of the
ﬁtting curve was carefully selected after a
10-ms delay of the decay or increment phase
of the current trace. The dashed line indicates
zero current level. (B) Cumulative results are
obtained from six cells with the experiments
described in panel A. (Left) The binding time
constants are 1156 12, 586 3, and 206 1ms
in the presence of 100, 300, and 1000 mM
FBM, respectively. (Right) The unbinding
time constants are 330 6 25, 319 6 17, and
321 6 23 ms after the wash-off of 100, 300,
and 1000 mM FBM, respectively. (C) The
inverses of the binding and unbinding time
constants in panel B are plotted against the
FBM concentration. The lines are linear re-
gressionﬁts to the two sets ofmean values. For
the binding rates, the slope and intercept are
4.6 3 104 M1 s1 and 3.5 s1, respectively.
For the unbinding rates, the intercept is 3.1 s1
and the slope is zero (i.e., an essentially
horizontal line indicating that the unbinding
rates are unrelated to the FBM concentration).
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of a functional NMDA channel in mammalian cells requires
four subunits, or a heterotetrameric combination of two NR1
and two NR2 subunits (24–26), but see (27)), with the
NMDA (or glutamate) and glycine binding sites located in
the NR2 and NR1 subunits, respectively (24,28–30). The
probability of NMDA channel activation would be greatly
increased only when all of the four sites, each in one of the
four subunits, are occupied by NMDA and glycine (two for
NMDA and two for glycine). In this regard, it is intriguing
that FBM effectively modulates the afﬁnity of both NMDA
and glycine (and thus the opening probability) of the NMDA
channel with a simple bimolecular reaction (i.e., a stoichi-
ometry of one-to-one binding to the channel). The subtle but
signiﬁcant difference in the basic features of FBM and NMDA
(or glycine) binding to the NMDA channel may suggest that
structurally the FBM binding site in the NMDA channel is
formed by more than one subunit. This would also be very
much consistent with the idea that the major effect of FBM
on the gating process is probably at a point where the allo-
steric effects of NMDA and glycine binding on NMDA chan-
nel gating have coalesced (see below).
FBM has quantitatively very similar enhancement
effect on NMDA and glycine binding to the
NMDA channel
We have seen that FBM binding modulates both the NMDA
and glycine binding to the NMDA channel. Detailed quanti-
tative analysis shows that the increase of afﬁnity is slight but
deﬁnite (approximately twofold). Most interestingly, the in-
crease of afﬁnity is quantitatively very similar for both NMDA
and glycine (based on the apparent dissociation constant or
on the opening probability when two molecules of NMDA or
glycine have bound to the channel; Figs. 1 A and 3 C). The
approximately twofold increase in NMDA or glycine afﬁnity
in our study is roughly consistent with the previously re-
ported effect of 1 mM FBM on the NMDA channel despite
the different experimental approaches in different studies (e.g.,
3.5-fold increase in NMDA afﬁnity, (3); 211% enhancement
in [3H]glycine binding, (15)). It is also consistent with the
ﬁnding that FBM has slightly stronger binding to the open
than to the closed NMDA channels (in view of the Kf,o/Kf,c¼
120 mM/300 mM, i.e., only 2.5-fold). Considering that NMDA
and glycine have separate binding sites in different subunits
of the NMDA channel and the one-to-one binding stoichi-
ometry between FBM and the channel, FBM most likely
allosterically interacts with both the NMDA and glycine sites
on the NMDA channel. The very similar quantitative effect
on NMDA and glycine binding may further imply that the
major molecular action of FBM on the gating process is
downstream of NMDA and glycine binding (i.e., at a point
where the effects of NMDA and glycine binding on NMDA
channel gating have coalesced). In other words, these ﬁnd-
ings suggest that NMDA and glycine binding should not
each control a completely separate part of the activation gate
of the channel (and it is unlikely that the channel is open
FIGURE 6 Binding rate of FBM to the resting NMDA
channel. (A) The neuron was repeatedly exposed to a 4 mM
NMDA pulse 0.3 s in length at a 60 s interval until stable
responses were achieved. FBM (300 mM) was then applied
to the cell for different periods of time (the preincubation
time) before the next NMDA exposure. The numbers above
the raw sweeps represent the FBM preincubation time. It
is evident that the NMDA current gets larger (and then
saturates) as the preincubation with FBM gets longer. (B)
The mean peak NMDA currents with different FBM pre-
incubation time are normalized to the peak control currents
(obtained without FBM preincubation), and plotted against
the FBMpreincubation time (n¼ 5–8). The lines are single-
exponential ﬁts of the form: relative current ¼ 1 1 0.5 3
(1  exp(t/14.5)) (t denotes length of the preincubation
time in seconds, the horizontal axis), 111.33 (1 exp(t/
8.6)), and 1 1 1.1 3 (1  exp(t/4.2)) for 100, 300, and
1000 mM FBM, respectively. (C) The inverses of the time
constants in panel B are plotted against the FBM concen-
tration. The line is a linear regression ﬁt to the data points
with a slope and an intercept of 187.5 M1 s1 and 5.4 3
102 s1, respectively.
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simply when all of its four separate parts are open). Instead,
the conformational changes induced by NMDA and glycine
binding in the four subunits seem to be interrelated to lead
into a signiﬁcant conformational change of the activation
gate and channel opening. The major action of FBM seems
to be at or after this point of intersubunit interaction, and thus
it has quantitatively very similar effects on both NMDA and
glycine binding to the channel. The FBM binding site thus
should be close to or right at the actual activation gate of the
NMDA channel. In this regard, it is interesting to note that in
contrast to the case at pH 7.4, the pore-blocking effect of
FBM on the NMDA channel becomes manifest at pH 8.4
(31). FBM thus is an opportunistic pore blocker of the
NMDA channel, very likely with its binding site located in
the pore, where the activation gate should also be located to
control ion permeation.
FBM is both an agonist and an antagonist of
glycine in the NMDA channel
We ﬁnd that FBM increases the afﬁnity of glycine binding to
the NMDA channel (Fig. 3) and dose-dependently enhances
the currents when the glycine concentration is extremely low
(e.g., 0.01 mM, Fig. 4). These ﬁndings, together with the idea
that FBM binding to NMDA channels is downstream from
the glycine and NMDA binding sites, imply that FBM is a
partial allosteric agonist of glycine. On the other hand, FBM
effectively modiﬁes NMDA channel gating by enhancement
of the activation and especially the desensitization processes,
but glycine may decrease NMDA channel desensitization
(Fig. 3 A; see also (22,23)). Desensitization of the NMDA
channel thus may potentiate FBM binding but attenuate
glycine binding, and FBM could have an allosteric antag-
onistic effect on glycine binding by enhancement of channel
desensitization. In other words, FBM is very likely an agonist
of glycine for channel activation but an antagonist of glycine
for channel desensitization, demonstrating delicate interac-
tions between FBM, glycine, and different gating conforma-
tions of the NMDA channel.
There are much larger gating conformational
changes at the entrance zone than in the binding
region(s) of the FBM binding site
Our previous study has demonstrated that FBM has an ap-
proximately two-to-fourfold higher afﬁnity to the activated
(open/desensitized) than to the resting (closed) states of
NMDA channels (4). In this study we further examined the
kinetics of FBM binding to and unbinding from the NMDA
channel in detail. The binding rates of FBM to the resting
and to the activated NMDA channels are 187.5 and 4.6 3
104 M1 s1, respectively (Figs. 5 and 6). The unbinding rates
of FBM from the resting and from the activated NMDA
channels are 5.4–6.2 3 102 and 3.1–3.5 s1, respectively
(Figs. 5 and 6). Harty and Rogawski (32) also measured the
binding and unbinding rate constants of FBM in the cloned
NMDA channels composed of NR1-2B subunits, but they
had focused on the NMDA-bound channels (i.e., not resting
channels) and reported binding and unbinding rate constants
of 1.6 3 104 M1 s1 and 5.0 s1, respectively. These data
are roughly consistent with our results obtained from neo-
natal (7–14-day-old) rat hippocampal neurons, in which the
main population of NMDA channels probably also contains
NR1-2B subunit (33). On the other hand, to the best of our
knowledge, there has been no precedent on the kinetics of
FBM binding to and unbinding from the resting NMDA
channel. Based on the binding and unbinding rate constants,
apparent dissociation constants of;300 and;70 mM could
be calculated for FBM binding to the resting and the acti-
vated NMDA channels, respectively. The slight (approxi-
mately fourfold) difference in FBM binding afﬁnity to the
resting and to the activated NMDA channels thus is actually
composed of much larger differences in the binding and
unbinding kinetics (;250- and ;60-fold difference, respec-
tively). These ﬁndings strongly suggest that the entrance zone
of the FBM binding site undergoes a much larger confor-
mational change along the gating process than the binding
region(s) of the binding site. In other words, the FBM bind-
ing site becomes much more accessible to FBM with NMDA
channel activation (and FBM could therefore more easily
bind to and unbind from its binding site in the activated than
FIGURE 7 Unbinding rate of FBM from the resting NMDA channel. The
unbinding rate of FBM from the resting NMDA channel was assessed by a
two-pulse protocol with a ﬁxed 40-s preincubation of 300 mM FBM. The
current was elicited by the ﬁrst NMDA pulse (4 mM, 0.3 s), and then a
similar NMDA pulse was given after different intervals of FBM wash-off.
The peak NMDA current in the second pulse is normalized to that in the ﬁrst
NMDA pulse and is plotted against the duration of the wash-off interval
(n ¼ 7). The line is a single-exponential ﬁt of the form: relative current ¼
1–0.653 (1  exp(t/16.2)) (t denotes length of wash-off time in seconds,
the horizontal axis).
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in the resting NMDA channel), but the spatial conﬁgurations
of the binding ligand(s) for FBM themselves are not altered
so much along the gating process. It would be desirable to
further differentiate the interactions of FBM with open and
desensitized NMDA channels, which may provide more mo-
lecular insight into the different gating states of the channel.
Recently, the molecular mechanisms of different types of
NMDA channel desensitization have been characterized in
more detail (36–38). This could be achieved when the
structure-function relationship of NMDA channel desensi-
tization becomes sufﬁciently clear, and then one may study
the interactions between FBM and different mutant NMDA
channels with different open and/or desensitization proper-
ties, possibly with the help of photolabile transmitters (39) or
other technical advances to minimize the diffusion time of
the applied transmitters and thus the resolution of different
gating states. In any case, as we have argued that the FBM
binding site is located close to or right at the activation gate
in the NMDA channel (see above), it would be especially
interesting to see in the future if the gated access of FBM to
its binding site is actually controlled by the activation gate of
the NMDA channel.
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